InvestorsHub Logo
Followers 23
Posts 1084
Boards Moderated 0
Alias Born 03/07/2013

Re: Tzr250rg post# 765

Thursday, 03/17/2022 1:27:13 PM

Thursday, March 17, 2022 1:27:13 PM

Post# of 811
Cantor Fitzgerald Reiterates VYNE Therapeutics (VYNE) Overwight, $10 PT, Sees Company's Bromodomain and Extra-Terminal Domain Inhibitors Programs are Under appreciated


https://www.streetinsider.com/Analyst+Comments/Cantor+Fitzgerald+Reiterates+VYNE+Therapeutics+%28VYNE%29+Overwight%2C+%2410+PT%2C+Sees+Companys+Bromodomain+and+Extra-Terminal+Domain+Inhibitors+Programs+are+Underappreciated/19790311.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VYNE News